Clinical Trial Update: A 6-week Study to Evaluate the Efficacy and Safety of Lurasidone HCL in Acutely Psychotic Patients With Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of lurasidone HCl in acutely psychotic patients with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Lurasidone HCl (lurasidone)

Snippet

Sponsor: Bukwang Pharmaceutical | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED